-
Vascular Health and Risk Management
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Fibrosis in diabetes complications: Pathogenic mechanisms and circulating and urinary markers
Review
(3354) Views (1059) Full article downloads
Authors: Camelia R Ban, Stephen M Twigg
Published Date June 2008
Volume 2008:4(3) Pages 575 - 596
DOI: http://dx.doi.org/10.2147/VHRM.S1991
Camelia R Ban, Stephen M Twigg
Discipline of Medicine and Department of Endocrinology, The University of Sydney and Royal Prince Alfred Hospital, Sydney, New South Wales, 2006, Australia
Abstract: Diabetes mellitus is characterized by a lack of insulin causing elevated blood glucose, often with associated insulin resistance. Over time, especially in genetically susceptible individuals, such chronic hyperglycemia can cause tissue injury. One pathological response to tissue injury is the development of fibrosis, which involves predominant extracellular matrix (ECM) accumulation. The main factors that regulate ECM in diabetes are thought to be pro-sclerotic cytokines and protease/anti-protease systems. This review will examine the key markers and regulators of tissue fibrosis in diabetes and whether their levels in biological fluids may have clinical utility.
Keywords: diabetic complications, extracellular matrix, markers
Readers of this article also read:
Combination treatment in the management of type 2 diabetes: focus on vildagliptin and metformin as a single tablet
Combining insulins with oral antidiabetic agents: effect on hyperglycemic control, markers of cardiovascular risk and disease
Early seizures in patients with acute stroke: Frequency, predictive factors, and effect on clinical outcome
Atherosclerotic lesions and mitochondria DNA deletions in brain microvessels: Implication in the pathogenesis of Alzheimer’s disease
The secretory phospholipase A2 group IIA: a missing link between inflammation, activated renin-angiotensin system, and atherogenesis?
Corrigendum: Softec HD hydrophilic acrylic intraocular lens: biocompatibility and precision
Erratum
Erratum
Association between diabetes complications and leukocyte counts in Iranian patients
- Join ISVH
Be part of the World's leading experts in vascular health by joining the International Society of Vascular Health (ISVH)
- Testimonials
"... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University
- The western diet and lifestyle and diseases of civilization
- Stiffness of the large arteries in individuals with and without Down syndrome
- Effects of Azelnidipine plus OlmesaRTAn versus amlodipine plus olmesartan on central blood pressure and left ventricular mass index: the AORTA study
- Vascular effects of rapid-acting insulin analogs in the diabetic patient: a review




